| Katie Cherenzia, | |
|
593 Eddy St, Providence, RI 02903-4923 | |
| (401) 444-7930 | |
| Not Available |
| Full Name | Katie Cherenzia |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Oncology |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871205443 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SX0200X | Clinical Nurse Specialist - Oncology | APRN02622 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katie Cherenzia, 593 Eddy St, Providence, RI 02903-4923 Ph: () - | Katie Cherenzia, 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 444-7930 |
News Archive
World Diabetes Day is on 14 November this year highlighting that diabetes is on the increase and to create awareness to aid prevention of figures growing larger. To help prevent diabetes becoming a burden to the NHS resources in the future, new research projects commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme will evaluate the effectiveness and cost-effectiveness of different screening tests used in diabetic eye care.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
The Salk Institute, which hosts a National Cancer Institute-designated cancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting-edge basic and translational research in cancer.
Researchers at Cincinnati Children's Hospital Medical Center have developed a new framework for different factors influencing how a child's brain is "wired" to learn to read before kindergarten.
› Verified 4 days ago
Ms. Laura Beth Chalk, PCNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 208 Governor St Fl 2, Providence, RI 02906 Phone: 401-383-4848 Fax: 401-383-4811 | |
Joan Mende Walsh, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-639-2933 | |
Linda Marie Mcbride, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 830 Chalkstone Ave, Providence, RI 02908 Phone: 401-273-7100 | |
Francine Pingitore, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5636 | |
Sally Harrison, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 16 Stimson Ave, Providence, RI 02906 Phone: 401-465-3362 Fax: 401-331-7575 | |
Kristen Marie Burton-williams, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-2504 | |
Janet Campbell Cameron, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 830 Chalkstone Ave, Providence, RI 02908 Phone: 401-273-7100 Fax: 401-457-3326 |